Research Matters

Through collaboration we all succeed

Through collaboration we all succeed

At Al Jalila Foundation we know that research has the power to advance medical breakthroughs that could save millions of lives and change the fabric of science as we know it. We also know that this goal will not be achieved alone and believe in the power and strength of our partnerships. M... Read more

Biochip technology shows potential for improved diagnostics

Biochip technology shows potential for improved diagnostics

Globally, diabetes is estimated to affect 420 million adults. Studies show that the prevalence of diabetes in the UAE is estimated to affect a quarter of the local population. Hematological (blood) disorders that occur in diabetes patients are found to put them at a higher risk for deve... Read more

Uncovering mechanisms to inhibit cancer cell growth

Uncovering mechanisms to inhibit cancer cell growth

According to the World Health Organization, cancer is the second leading cause of death globally with about 1 in 6 deaths due to cancer. The main reason why it is so lethal is that cancer cells spread from their primary growth site to different body organs, a process known as metastasis. T... Read more

Research focuses on antioxidants to tackle obesity

Research focuses on antioxidants to tackle obesity

Al Jalila Foundation is committed to be a leader in medical research and in our mission to discover innovative solutions to address the medical challenges of the future we engage with the greatest minds in the UAE. Professor Salah Gariballa, from UAE University, is one scientific leader wh... Read more

Scientist develops diagnostics for diabetic retinopathy

Scientist develops diagnostics for diabetic retinopathy

In the UAE, there are nearly 756,000 people diagnosed with diabetes and reports suggest that about 300,000 are undiagnosed. Diabetic retinopathy (DR) is a major complication of diabetes and can lead to vision loss if untreated. Innovative and comprehensive approaches are urgently needed to... Read more

Pioneering epigenetic-based analysis for liver cancer

Pioneering epigenetic-based analysis for liver cancer

Liver cancer is a leading cause of cancer-related deaths worldwide and the sixth most prevalent cancer in the GCC countries. A survey by the Health Authority of Abu Dhabi reported liver cancer as the tenth most common cancer in the UAE and one of the top five leading causes of death in mal... Read more

Developing novel treatment for COVID-19

Developing novel treatment for COVID-19

COVID-19 has disrupted the world, produced chaos and posed a significant threat to global health. Since the first outbreak, several treatments have been developed to prevent the spread of this virus with many vaccines approved and extensively administered. However, the fact that SARS-CoV-2... Read more

Pioneering breast cancer research gives hope

Pioneering breast cancer research gives hope

In the UAE, breast cancer is the most common cancer affecting women and constitutes around 40% of all female cancers. In addition to the rising incidence, another cause for concern is the advanced stage at presentation with the majority of women in the UAE diagnosed under the age of 40 wit... Read more

Improving treatment for liver cancer

Improving treatment for liver cancer

Liver cancer is one of the most common cancers worldwide and incidence is increasing dramatically in the Gulf region. As treatment options are limited Al Jalila Foundation awarded a research grant to Dr Kirsten Sadler Edepli from New York University Abu Dhabi who is looking at targeting... Read more

Smoking increases the spread of cancer

Smoking increases the spread of cancer

Smoking is the number one risk factor for lung cancer and tobacco smokers are at 20 to 40 times higher risk of developing lung cancer in comparison to non-smokers. With a research grant from Al Jalila Foundation, Dr Rania Zaarour from Gulf Medical University Ajman, is studying the effec... Read more